Calcinosis Reduction by Pyrophosphate in SSC
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSzeged University
Calcinosis, i.e. crystal-like nodules are troublesome complication of systemic sclerosis, an autoimmune disease. Pyrophosphate inhibits its formation is laborytory. We would like to test if orally administered pyrophosphate prevents calcinosis formation.
to meet ACR/ EULAR classification criteria
severe upper minfestation of SSC
hypo- or hyperthyreoidism
QT prolongation on ECG
Szeged University
Lead sponsor
Research Centre for Natural Sciences
Collaborator
University of Debrecen Dept. of Rheumatology
Collaborator